Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-23

Clinical Trial Update: Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial update examining the effect of Januvia on beta cell function in Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Januvia (sitagliptin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED